Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,854
datasets available to search
ShareScore release 0.9.0
Dataset results
2,854 results for “hepatocellular carcinoma”
The Combination Therapy of TACE and Ablation With Durvalumab in Hepatocellular Carcinoma at Intermediate Stage (TAD)
ClinicalTrials.gov study NCT04517227. IPD Sharing: NO. Countries: 0. Publications: 0.
Comparing the Combination of Trastuzumab and Regorafenib With Regorafenib Monotherapy for Advanced Hepatocellular Carcinoma After First-line Treatment
ClinicalTrials.gov study NCT07078305. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Phase II Single-Arm Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Lenvatinib and TACE for Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT07150377. IPD Sharing: NO. Countries: 0. Publications: 0.
The Efficacy of Transarterial Chemoinfusion (TAI) Combine Toripalimab in Advanced Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT03851939. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Volumetric Analysis of Hepatocellular Carcinoma After Transarterial Chemoembolization
ClinicalTrials.gov study NCT04780789. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Effect of Biejia-Ruangan Compound on Survival Rate and Recurrence Rate of Hepatocellular Carcinoma After Radical Treatment
ClinicalTrials.gov study NCT06923176. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Phase II Clinical Study on the Efficacy and Safety of the Combination of Cadonilimab and Capecitabine in Adjuvant Therapy for Combined Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT07243951. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Yttrium Y 90 Glass Microspheres, Atezolizumab, and Cabozantinib for the Treatment of Unresectable or Locally Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05327738. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study of ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma
ClinicalTrials.gov study NCT00319683. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Clinical Intervention Strategy for High-risk Group of Hepatitis B Related Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05256459. IPD Sharing: NO. Countries: 0. Publications: 0.
TACE Combined With Lenvatinib for Unresectable Hepatocellular Carcinoma (Prolong)
ClinicalTrials.gov study NCT04560751. IPD Sharing: NO. Countries: 0. Publications: 0.
The Study of The Treatment of Postoperative Adjuvant Apatinib vs. TACE in Hepatocellular Carcinoma Patients
ClinicalTrials.gov study NCT03511703. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ATEZOLIZUMAB - BEVACIZUMAB in the Treatment Hepatocellular Carcinoma Inoperable or
ClinicalTrials.gov study NCT04730388. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Efficacy and Safety of Yttrium-90 Microspheres Selective Internal Radiotherapy Combined with Immune Checkpoint Inhibitors and Anti-angiogenesis Drugs Sequential HAIC for Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06867432. IPD Sharing: NO. Countries: 0. Publications: 0.
Role of LDH as a Predictor of Treatment Outcomes in Hepatocellular Carcinoma
ClinicalTrials.gov study NCT03338166. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT07351513. IPD Sharing: NO. Countries: 0. Publications: 0.
Clinical Study of MRD Recurrence Monitoring After Surgical Resection of Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05458115. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Outcome of Transarterial Chemo-embolization (TACE) in Hepatocellular Carcinoma Patients With Partial Portal Vein Thrombosis
ClinicalTrials.gov study NCT03007212. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Evaluation of the Efficacy of Long-acting Release Octreotide in Patients With Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT00241020. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Annexin A2 as a Novel Diagnostic Marker in Hepatocellular Carcinoma
ClinicalTrials.gov study NCT02541149. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.